BioMerieux SA (BMXMF)
98.75
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
BioMerieux Total Assets (Quarterly): 5.814B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.814B |
| June 30, 2023 | 5.467B |
| June 30, 2023 | 5.467B |
| December 31, 2022 | 5.562B |
| June 30, 2022 | 5.266B |
| June 30, 2022 | 5.266B |
| December 31, 2021 | 5.214B |
| June 30, 2021 | 4.947B |
| June 30, 2021 | 4.947B |
| December 31, 2020 | 4.831B |
| June 30, 2020 | 4.644B |
| June 30, 2020 | 4.644B |
| December 31, 2019 | 4.236B |
| June 30, 2019 | 4.147B |
| June 30, 2019 | 4.147B |
| December 31, 2018 | 4.009B |
| June 30, 2018 | 3.477B |
| June 30, 2018 | 3.477B |
| December 31, 2017 | 3.587B |
| June 30, 2017 | 3.344B |
| June 30, 2017 | 3.344B |
| Date | Value |
|---|---|
| December 31, 2016 | 3.202B |
| June 30, 2016 | 3.068B |
| June 30, 2016 | 3.068B |
| December 31, 2015 | 3.032B |
| June 30, 2015 | 2.999B |
| June 30, 2015 | 2.999B |
| December 31, 2014 | 3.138B |
| June 30, 2014 | 3.175B |
| June 30, 2014 | 3.175B |
| December 31, 2013 | 3.033B |
| June 30, 2013 | 2.399B |
| June 30, 2013 | 2.399B |
| December 31, 2012 | 2.452B |
| June 30, 2012 | 2.249B |
| June 30, 2012 | 2.249B |
| December 31, 2011 | 2.301B |
| June 30, 2011 | 2.128B |
| December 31, 2010 | 1.927B |
| June 30, 2010 | 1.694B |
| December 31, 2009 | 1.803B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.147B
Minimum
Jun 2019
5.814B
Maximum
Dec 2023
4.973B
Average
4.947B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 354.46M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 192.20M |
| Innate Pharma SA | 203.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.666B |
| Shareholders Equity (Quarterly) | 4.148B |
| Debt to Equity Ratio | 0.0987 |
| Current Ratio | 2.028 |
| Net Debt Paydown Yield | 0.22% |